“让中国肿瘤事业在国际上前进了一大步”这句话不足以概括储大同教授对中国肿瘤事业的贡献。由他牵头创建的中国抗癌协会临床肿瘤学协作专业委员会(CSCO),是继美国临床肿瘤学会(ASCO)和欧洲临床肿瘤学会(ESMO)之后的世界第三大临床肿瘤学术组织,此举实现了中国肿瘤界与国际的全面接轨。之后,储大同又发起并参与创建了中国老年学学会老年肿瘤专业委员会(CGOS),开创了一个完全空白的阵地。在40多年的行医生涯中,除了这两个他人难以超越的代表性成果,人们对储大同教授最中肯的褒奖是:一个纯粹的医学痴迷者。 “Let the Chinese cancer cause a big step forward in the international community, ” This sentence is not enough to summarize Professor Datong’s contribution to the cause of cancer in China. The Chinese Society of Clinical Oncology Collaborative Professional Committee (CSCO), led by him, is the world’s third largest clinical oncology academic organization following the American Society of Clinical Oncology (ASCO) and the European Society of Clinical Oncology (ESMO) The full integration of Chinese oncology and the international community. Later, Chu Datong launched and participated in the creation of the Chinese Gerontology Society of Gerontology oncology (CGOS), creating a completely blank position. In more than 40 years of medical practice, in addition to these two other hard-to-reach representational achievements, the most pertinent testimony to Professor Datong Datong is: a purely medical fanatics.